Stock Track | Applied Therapeutics Inc. Plummets 5.42% After UBS Downgrades to Neutral, Slashes Price Target

Stock Track

2024/12/03

Applied Therapeutics Inc. (APLT) shares plummeted by 5.42% in the pre-market session on Monday, December 2, 2024, following a significant downgrade and price target cut by UBS analysts.

According to UBS, they have downgraded their rating on Applied Therapeutics from Buy to Neutral, citing concerns about the company's prospects. Along with the downgrade, UBS has also slashed their price target for the stock from $13 to just $2.

The steep downgrade and price target reduction by a prominent Wall Street firm like UBS appears to be the primary driver behind the sharp sell-off in Applied Therapeutics' shares on Monday morning.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1115794827"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1115794827\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1115794827?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-03 17:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115794827","market":"hk","top_or_hot":-1,"title":"Stock Track | Applied Therapeutics Inc. Plummets 5.42% After UBS Downgrades to Neutral, Slashes Price Target","media":"Stock Track","content":"<p>Applied Therapeutics Inc. (APLT) shares plummeted by 5.42% in the pre-market session on Monday, December 2, 2024, following a significant downgrade and price target cut by UBS analysts.</p>\n\n<p>According to UBS, they have downgraded their rating on Applied Therapeutics from Buy to Neutral, citing concerns about the company's prospects. Along with the downgrade, UBS has also slashed their price target for the stock from $13 to just $2.</p>\n\n<p>The steep downgrade and price target reduction by a prominent Wall Street firm like UBS appears to be the primary driver behind the sharp sell-off in Applied Therapeutics' shares on Monday morning.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Applied Therapeutics Inc. Plummets 5.42% After UBS Downgrades to Neutral, Slashes Price Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Applied Therapeutics Inc. Plummets 5.42% After UBS Downgrades to Neutral, Slashes Price Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2024-12-03 17:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Applied Therapeutics Inc. (APLT) shares plummeted by 5.42% in the pre-market session on Monday, December 2, 2024, following a significant downgrade and price target cut by UBS analysts.</p>\n\n<p>According to UBS, they have downgraded their rating on Applied Therapeutics from Buy to Neutral, citing concerns about the company's prospects. Along with the downgrade, UBS has also slashed their price target for the stock from $13 to just $2.</p>\n\n<p>The steep downgrade and price target reduction by a prominent Wall Street firm like UBS appears to be the primary driver behind the sharp sell-off in Applied Therapeutics' shares on Monday morning.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"APLT","symbol_name":"Applied Therapeutics Inc.","start_time":0,"source_url":"","article_id":"1115794827","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115794827","pubTimestamp":1733217975,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Applied Therapeutics Inc.  shares plummeted by 5.42% in the pre-market session on Monday, December 2, 2024, following a significant downgrade and price target cut by UBS analysts.According to UBS, they have downgraded their rating on Applied Therapeutics from Buy to Neutral, citing concerns about the company's prospects. Along with the downgrade, UBS has also slashed their price target for the stock from $13 to just $2.The steep downgrade and price target reduction by a prominent Wall Street fir","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"APLT":"Applied Therapeutics Inc."},"translate_title":"瑞银将评级下调至中性并下调目标价后，Applied Therapeutics Inc.股价暴跌5.42%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APLT":1},"content_text":"Applied Therapeutics Inc. (APLT) shares plummeted by 5.42% in the pre-market session on Monday, December 2, 2024, following a significant downgrade and price target cut by UBS analysts.\nAccording to UBS, they have downgraded their rating on Applied Therapeutics from Buy to Neutral, citing concerns about the company's prospects. Along with the downgrade, UBS has also slashed their price target for the stock from $13 to just $2.\nThe steep downgrade and price target reduction by a prominent Wall Street firm like UBS appears to be the primary driver behind the sharp sell-off in Applied Therapeutics' shares on Monday morning.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}